Edition:
United States

Neuralstem Inc (CUR.OQ)

CUR.OQ on NASDAQ Stock Exchange Capital Market

1.56USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
187,697
52-wk High
$6.58
52-wk Low
$0.89

Chart for

About

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189... (more)
No analyst recommendations are available for .

Overall

Beta: 1.58
Market Cap(Mil.): $23.63
Shares Outstanding(Mil.): 15.15
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.23 16.73
EPS (TTM): -- -- --
ROI: -- 14.02 35.60
ROE: -- 15.49 17.23

BRIEF-Neuralstem Q3 loss per share $0.01

* Neuralstem reports third quarter 2017 fiscal results and provides clinical and business update

Nov 13 2017

BRIEF-Neuralstem Inc appoints two members to its board

* Neuralstem announces the appointment of two new members to the board of directors

Sep 25 2017

BRIEF-Neuralstem Inc gets two additional U.S. patents

* Neuralstem Inc - ‍been awarded two additional patents by United States Patent and Trademark Office​ Source text for Eikon: Further company coverage:

Sep 07 2017

Earnings vs. Estimates